Anticompetitive Patent Settlements and the Supreme Court's Actavis Decision

SSRN Electronic Journal
doi 10.2139/ssrn.2286255
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Hatch-Waxman Patent Case Settlements the Supreme Court Churns the Swamp

SSRN Electronic Journal
2013English

The First Congress Canon and the Supreme Court's Use of History

California Law Review
Law
2006English

Settlements in the Supreme Court of Israel

AJIL Unbound
Law
2017English

Legal Report: UR Here: The Supreme Court's Guide for Managed Care

Health Affairs
MedicineHealth Policy
2000English

Secular Idolatry and Sacred Traditions: A Critique of the Supreme Court's Secularization Analysis

University of Pennsylvania Law Review
Law
1998English

A Capital Waste of Time? Examining the Supreme Court's 'Culture of Death'

SSRN Electronic Journal
2008English

Canada's Supreme Court Abolishes ‘Promise of the Patent’

Pharmaceutical patent analyst
MedicineDrug DiscoveryPharmaceutical Science
2018English

Reverse Payment Patent Settlements in the Pharmaceutical Sector and Competition Law – Do Lundbeck and Actavis Help to Bridge the Views Across the Atlantic Regarding the Delayed Market Entry of Cheaper, Generic Medicines?

International and Comparative Law Review
Law
2013English

“Patent Unreasonableness Is Dead. And We Have Killed It.” a Critique of the Supreme Court of Canada’s Decision in Dunsmuir

Alberta Law Review
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy